You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
8 November 2013
CereSpir Incorporated Secures Exclusive Worldwide Development and Commercialization Rights for CHF 5074 From Chiesi Farmaceutici S.p.A.
26 July 2013
CereSpir Incorporated Announces Letter of Intent With Chiesi Farmaceutici SpA, to License Worldwide Development and Commercialization Rights for CHF 5074 to CereSpir